Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Nephritis”

372 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 372 results

Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Not applicableWithdrawnNCT00908986
What this trial is testing

Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

Who this might be right for
Lupus Nephritis
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Testing effectiveness (Phase 2)UnknownNCT06113900
What this trial is testing

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Who this might be right for
Lupus Nephritis
Ain Shams University 50
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Not applicableStudy completedNCT01156428
What this trial is testing

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Who this might be right for
ProteinuriaKidney InjuryChronic Kidney Disease
The Rogosin Institute 119
Large-scale testing (Phase 3)UnknownNCT04892212
What this trial is testing

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Who this might be right for
Lupus NephritisImmunosuppressionEffect of Drug
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT05288855
What this trial is testing

Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis

Who this might be right for
Adolescent Lupus NephritisPediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc. 9
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03747159
What this trial is testing

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Who this might be right for
Lupus Erythematosus, Systemic
Leiden University Medical Center 70
Not applicableNot Yet RecruitingNCT06610422
What this trial is testing

Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Nephritis
Assiut University 159
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Not applicableStudy completedNCT05195086
What this trial is testing

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

Who this might be right for
Lupus Nephritis
Nada Magdy Mansour 122
Large-scale testing (Phase 3)Ended earlyNCT01765842
What this trial is testing

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

Who this might be right for
Lupus Nephritis
Fundación Pública Andaluza Progreso y Salud 9
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)Study completedNCT06717815
What this trial is testing

Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd 24
Next Page